Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • Raspberry
    Participant
    Post count: 273

    I thought this 2013 study might be of some interest….I wonder too whether this will imply that hypothyroidism (from any cause) combined with Graves antibodies will encourage TED? I know that my own eye symptoms seem to worsen when my Free T’s have been on the low side of the normal range from taking methimazole.

    Here’s the conclusion from the study:

    Quote:
    CONCLUSIONS: The presence of hypothyroidism at the first assessment of thyroid function after RAI administration is a strong predictor for adverse GO outcome. This risk is highest in patients with preexisting GO. We suggest that in order to prevent clinical hypothyroidism and the associated risk for GO, the optimal time for first measurement of fT4 is before 6 weeks after RAI therapy.

    Study link

    Kimberly
    Keymaster
    Post count: 4294

    @Raspberry – The ATA recently did a review of this study, and they actually recommend follow ups at the 4-week mark, *just* to make sure that hypothyroidism is caught early:

    (Note on links: if you click directly on the following link, you will need to use your browser’s “back” button to return to the boards after viewing, or you will have to log back in to the forum. As an alternative, you can right-click the link and open it in a new tab or new window).

    http://thyroid.org/thyroid-physicians-professionals/thyroid-disease-information/clinical-thyroidology/june-2013-volume-25-issue-6/clin-thyroidol-201325132-133/

    Raspberry
    Participant
    Post count: 273

    I’m glad you replied Kimberly that’s good to know about the four weeks – seems like by six weeks it might be too late. It was freaking me out seeing 116 views and no replies….guess people like to read about it at least!

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.